Our Recommendations
New Publications
- Guidelines on long-acting injectable cabotegravir for HIV prevention (2022)
- Differentiated and simplified pre-exposure prophylaxis for HIV prevention: update to WHO implementation guidance (2022)
- Improving the Quality of PrEP Implementation for Adolescent Girls and Young Women: An implementation brief to support programming in Eastern and Southern Africa (2021)
- Consolidated HIV guidelines for prevention, treatment, service delivery & monitoring (2021)
- Herramienta de estimación de necesidades y costos de la profilaxis preexposición (PrEP). Instruccciones de uso (2022)
Filter
35
Featured
Recommendations
2
Language
Document type
Guidelines
23
Studies & Reports
6
Fact sheets
4
Infographics
1
No document type
1
Countries / Regions
East and Southern Africa
1
South Africa
1
Authors & Publishers
Publication Years
Category
HIV & STI
2
Information, Education and Communication (IEC)
1
Toolboxes
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
35
Clinical Aspects
2
Antiretroviral Treatment ART
2
ART Drug Resistance
1
HIV testing & services
1
Opportunistic Infections
1
Prevention Guidelines
1
Treatment Guidelines HIV
1
Access to treatment and laboratory
1
Women
1
Prophylactic Treatment
1
HIV service delivery
1
Eastern and Southern Africa
1
Eastern Europe and central Asia
1
• PrEP is highly effective in preventing the sexual transmission of HIV.
• For PrEP to work well, it’s important to take the pills regularly.
• While PrEP can prevent HIV, it does not protect against other sexually transmitted infections.
Providing expert scientific advice on HIV
EAGA Secretariat
Supplement Article
WHO Guidelines for HIV PEP • CID 2015:60 (Suppl 3), S161 - S164
This briefing paper provides an overview of pre-exposure prophylaxis (PrEP) for people planning, commissioning or providing HIV prevention activities in the UK. It does this by reviewing thirty key questions about PrEP and how it might be implemented in the UK.
Pre-exposure prophylaxis (PrEP)
Policy Brief
November 2015
Supplement Article
Antiretrovirals to Prevent HIV Infection • CID 2015:60 (Suppl 3) • S159 - S160
Technical report
February 2015
Module 4
Leaders
July 2017
Module 4: Leaders. This module aims to inform and update leaders and decision-makers about PrEP. It provides information on the benefits and limitations of PrEP so that they can consider how PrEP could be effectively implemented in their own settings. It also contai...
Module 6
Pharmacists
July 2017
Module 6: Pharmacists. This module is for pharmacists and people working in pharmacies. It provides information on the medicines used in PrEP, including on storage conditions. It gives suggestions for how pharmacists and pharmacy staff can monitor PrEP adherence...
Module 8
Site Planning
July 2017
Module 8: Site planning. This module is for people involved in organizing PrEP services at specific sites. It outlines the steps to be taken in planning a PrEP service and gives suggestions for personnel, infrastructure and commodities that could be considered...
Module 9
Strategic planning
July 2017
Module 9: Strategic planning. As WHO recommends offering PrEP to people at substantial HIV risk, this module offers public health guidance for policy-makers on how to prioritize services, in order to reach those who could benefit most from PrEP, and in wh...
Module 10
Testing providers
July 2017
Module 10: Testing providers. This module is for people who provide testing services at PrEP sites and laboratories. It offers guidance in selecting testing services, including screening of individuals before PrEP is initiated and monitoring while they ar...
Module 1q
PrEP users
July 2017
Module 11: PrEP users. This module provides information for people who are interested in taking PrEP to reduce their risk of acquiring HIV and people who are already taking PrEP – to support them in their choice and use of PrEP. This module gives ideas for cou...
Guidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents, and children: recommendations for a public health approach : December 2014 supplement to the 2013 Consolidated guidelines on the use of antiretroviral drugs...
